
Brackenridge's Medical Selection of Life Risks
Palgrave Macmillan (Publisher)
5th Edition
Published on 14. January 2014
Book
Paperback/Softback
1094 pages
978-1-349-72326-3 (ISBN)
Description
The fifth edition of this leading reference book on insurance medicine, provides a comprehensive guide to life expectancy for underwriters and clinicians involved in the life insurance industry. Extensively revised and expanded, the new edition reflects developments in life and healthcare insurance as well as medicine.
More details
Series
Edition
5th 2006 ed.
Language
English
Place of publication
London
United Kingdom
Product notice
Paperback (trade)
Unsewn / adhesive bound
Illustrations
Bibliography
Dimensions
Height: 246 mm
Width: 189 mm
ISBN-13
978-1-349-72326-3 (9781349723263)
DOI
10.1007/978-1-349-72324-9
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions

R.D.C. Brackenridge | R. Croxson | Ross Mackenzie
Brackenridge's Medical Selection of Life Risks
Book
06/2006
5th Edition
Palgrave Macmillan
€534.99
Shipment within 10-20 days
Persons
RICHARD E. BRAUN MD, Senior Vice President and Medical Director, LabOne Inc, Lenexa, Kansas, USA
GARY BUNDOCK FCII DMU (AMS), Divisional Underwriting Consultant, Swiss Re Life and Health, London, UK
SHANKLIN B. CANNON MD, Medical Director, Northwestern Mutual Life Insurance Company, Milwaukee, Wisconsin, USA
MICHAEL CLARK Senior Vice President and Chief Medical Director, Swiss Re Life and Health, Armonk, New York, USA
GORDON R. CUMMING MD FRCP(C) FACC, Vice President and Medical Director, The Great West Life Assurance Company, Winnipeg, Manitoba, Canada
DANIEL C. ELLIOTT MD, Consultant, Long Term Care
MARTIN L. ENGMAN MD, International Medical Risk Consultants Inc., Fort Wayne, Indiana, USA
LINDA GOODWIN MD FACP, Internist, Geriatrician and President, Creative Risks Analysis, Inc,. Concord, North Carolina, USA
POLLY GALBRAITH MD, Vice President and Chief Medical Director, Assurant Employee Benefits
ROGER HARBIN FSA, Chief Operating Officer, SAFECO Life Insurance Company, Seattle, Washington, USA
DAVID E. HODGKINSON BSc (Hons) DMU (AMS), Implementation Consultant, Swiss Re Life and Health, London, UK
MICHAEL W. KITA MD (deceased) Formerly Vice President and Senior Medical Director, UNUM Life Insurance Company, Portland, Maine, USA
ROSS LAWRENSON MD MRCGP MFPHM FAPHM, Professor of Primary Care and Head of the Waikato Clinical School, University of Auckland, New Zealand
JOHN LOCASCIO Vice President and Senior Medical Director, UNUM Provident, Portland, Maine, USA
J. ALEXANDER LOWDEN MD PhD FRCP(C) FCCMG, Senior Vice President and Medical Director, LabOne Inc.
PETER C. MAYNARD FCII, Director, SelextX Ltd., Princes Risborough, Buckinghamshire, UK
HOWARD L. MINUK MD FRCP (C) ABIM, Chief Medical Officer, Swiss Re Life and Health, Toronto, Ontario, Canada
JAN VON OVERBECK MD MSc, Chief Medical Officer, Swiss Re, Zurich, Switzerland
RODNEY C. RICHIE MD FCCP, Texas Life Insurance Company, Waco, Texas, Medical Director, Professional Medical Services Inc., Waco, Texas
GEOFFREY H. ROBB MB FRCP, Consulting Diabetologist, Epsom General Hospital, Chief Medical Officer, Friends Provident, Pension Annuity Friendly Society, RGA (UK) Ltd., UK
F. CLIFFORD ROSE MB FRCP, Director, London Neurological Centre, London, UK
EMILIO RUBI (deceased) Formerly Technical Director, Underwriting, Long Term Care Division, GE Capital Assurance, California, USA
JAMES A. RYAN JR. MD FACP (deceased) Formerly Medical Consultant, Transamerica Life Companies, Los Angeles, California, USA
RICHARD B. SINGER MD, Consultant to American Academy of Insurance Medicine and formerly Second Vice President and Director of Medical Research, New England Life Insurance Company, Boston, Massachusetts, USA
PATRICK D. SNOW MD, Vice President and Chief Medical Director, Thrivent Financial for Lutherans, Appleton, Wisconsin, USA
KEVIN SOMERVILLE DM FRCP FRACP, Global Medical Consultant, Swiss Re Life and Health, London, UK
MAXWELL E.C. THORPE MD FRACP, Consultant Gastroenterologist, Prince of Wales Hospital, Sydney and Chief Medical Officer, Swiss Re Life and Health, Australia
ANTHONY D. TOFT CBE MD FRCP, Consultant Physician and Endocrinologist, Royal Infirmary, Edinburgh and Chief Medical Officer, Aegon UK, Edinburgh, UK
URSULA WANDL MD, Medical Director, Swiss Re Germany AG, Munich, Germany
ROBERT W. WATSON MD FLMI, Vice President and Chief Medical Officer, Allianz Life Insurance Company of North America, Minneapolis, Minnesota, USA
RICHARD WILLETS MA FFA, Consultant Actuary
HARRY A. WOODMAN FSA FALU ChFC, Consultant Actuary
ANNELIES S. ZINKERNAGEL MD, University Hospital Zurich, Switzerland
GARY BUNDOCK FCII DMU (AMS), Divisional Underwriting Consultant, Swiss Re Life and Health, London, UK
SHANKLIN B. CANNON MD, Medical Director, Northwestern Mutual Life Insurance Company, Milwaukee, Wisconsin, USA
MICHAEL CLARK Senior Vice President and Chief Medical Director, Swiss Re Life and Health, Armonk, New York, USA
GORDON R. CUMMING MD FRCP(C) FACC, Vice President and Medical Director, The Great West Life Assurance Company, Winnipeg, Manitoba, Canada
DANIEL C. ELLIOTT MD, Consultant, Long Term Care
MARTIN L. ENGMAN MD, International Medical Risk Consultants Inc., Fort Wayne, Indiana, USA
LINDA GOODWIN MD FACP, Internist, Geriatrician and President, Creative Risks Analysis, Inc,. Concord, North Carolina, USA
POLLY GALBRAITH MD, Vice President and Chief Medical Director, Assurant Employee Benefits
ROGER HARBIN FSA, Chief Operating Officer, SAFECO Life Insurance Company, Seattle, Washington, USA
DAVID E. HODGKINSON BSc (Hons) DMU (AMS), Implementation Consultant, Swiss Re Life and Health, London, UK
MICHAEL W. KITA MD (deceased) Formerly Vice President and Senior Medical Director, UNUM Life Insurance Company, Portland, Maine, USA
ROSS LAWRENSON MD MRCGP MFPHM FAPHM, Professor of Primary Care and Head of the Waikato Clinical School, University of Auckland, New Zealand
JOHN LOCASCIO Vice President and Senior Medical Director, UNUM Provident, Portland, Maine, USA
J. ALEXANDER LOWDEN MD PhD FRCP(C) FCCMG, Senior Vice President and Medical Director, LabOne Inc.
PETER C. MAYNARD FCII, Director, SelextX Ltd., Princes Risborough, Buckinghamshire, UK
HOWARD L. MINUK MD FRCP (C) ABIM, Chief Medical Officer, Swiss Re Life and Health, Toronto, Ontario, Canada
JAN VON OVERBECK MD MSc, Chief Medical Officer, Swiss Re, Zurich, Switzerland
RODNEY C. RICHIE MD FCCP, Texas Life Insurance Company, Waco, Texas, Medical Director, Professional Medical Services Inc., Waco, Texas
GEOFFREY H. ROBB MB FRCP, Consulting Diabetologist, Epsom General Hospital, Chief Medical Officer, Friends Provident, Pension Annuity Friendly Society, RGA (UK) Ltd., UK
F. CLIFFORD ROSE MB FRCP, Director, London Neurological Centre, London, UK
EMILIO RUBI (deceased) Formerly Technical Director, Underwriting, Long Term Care Division, GE Capital Assurance, California, USA
JAMES A. RYAN JR. MD FACP (deceased) Formerly Medical Consultant, Transamerica Life Companies, Los Angeles, California, USA
RICHARD B. SINGER MD, Consultant to American Academy of Insurance Medicine and formerly Second Vice President and Director of Medical Research, New England Life Insurance Company, Boston, Massachusetts, USA
PATRICK D. SNOW MD, Vice President and Chief Medical Director, Thrivent Financial for Lutherans, Appleton, Wisconsin, USA
KEVIN SOMERVILLE DM FRCP FRACP, Global Medical Consultant, Swiss Re Life and Health, London, UK
MAXWELL E.C. THORPE MD FRACP, Consultant Gastroenterologist, Prince of Wales Hospital, Sydney and Chief Medical Officer, Swiss Re Life and Health, Australia
ANTHONY D. TOFT CBE MD FRCP, Consultant Physician and Endocrinologist, Royal Infirmary, Edinburgh and Chief Medical Officer, Aegon UK, Edinburgh, UK
URSULA WANDL MD, Medical Director, Swiss Re Germany AG, Munich, Germany
ROBERT W. WATSON MD FLMI, Vice President and Chief Medical Officer, Allianz Life Insurance Company of North America, Minneapolis, Minnesota, USA
RICHARD WILLETS MA FFA, Consultant Actuary
HARRY A. WOODMAN FSA FALU ChFC, Consultant Actuary
ANNELIES S. ZINKERNAGEL MD, University Hospital Zurich, Switzerland
Content
PART ONE A Historical Survey of the Development of Life Assurance; R.D.C.Brackenridge Forms of Life and Health Insurance Contracts; P.C.Maynard Principles of Risk Selection and Classification; H.A.Woodman The Application of Life Table Methodology to Risk Appraisal; R.B.Singer The Rating of Substandard Lives; M.W.Kita Underwriting Genetic Diseases; J.A.Lowden Underwriting Older Ages; L.Goodwin Underwriting Younger Ages; P.D.Snow Disability Insurance; J.LoCascio Long Term Care Underwriting; D.C.Elliott & E.Rubi Impaired Lives Annuities; G.H.Robb & R.Willets Structured Settlements; J.A.Ryan Jr. & R.Harbin Application Processing; G.Bundock Life Underwriting and Information Technology; D.E.Hodkinson PART TWO The Concept of Health and Disease; R.D.C.Brackenridge The Medical Examination; R.D.C.Brackenridge Drawing Conclusions From Test Results; R.E.Braun Build; K.Somerville Blood Pressure; R.D.C.Brackenridge Diabetes Mellitus; G.H.Robb & R.Lawrenson Cardiovascular Disorders: Part A: Coronary Heart Disease; B.R.MacKenzie Part B: Arrhythmias, Valvular and other Disorders; R.S.Croxson Part C: Congenital; G.R.Cumming Electrocardiography; M.Clark Respiratory Disorders; R.C.Richie & M.L.Engman Disease of the Kidney and Urinary Tract; H.L.Minuk Disease of the Liver and Alimentary Tract; M.E.C.Thorpe Oncology; S.B.Cannon Blood Disorders; U.Wandl Endocrine Disorders; A.D.Toft Diseases of the Nervous System; F.C.Rose Psychiatric Disorders; U.Wandl Substance Abuse: Part A: Drugs and Alcohol; R.W.Watson Part B: Tobacco; R.W.Watson Rheumatic Disorders; R.D.C.Brackenridge Musculoskeletal Disorders; R.D.C.Brackenridge Infectious Diseases; J.von Overbeck HIV and AIDS; J.von Overbeck Tropical Diseases; J.von Overbeck & A.S.Zinkernagel Female Reproductive Disorders; P.Galbraith Miscellaneous Impairments; R.D.C.Brackenridge